Peptidylglycine ␣-amidating monooxygenase (PAM), an integral membrane protein essential for the biosynthesis of amidated peptides, was used to assess the role of cytosolic acidic clusters in trafficking to regulated secretory granules. Casein kinase II phosphorylates Ser 949 and Thr 946 of PAM, generating a short, cytosolic acidic cluster. P-CIP2, a protein kinase identified by its ability to interact with several juxtamembrane determinants in the PAM cytosolic domain, also phosphorylates Ser 949 . Antibody specific for phospho-Ser 949 -PAM-CD demonstrates that a small fraction of the PAM-1 localized to the perinuclear region bears this modification. Pituitary cell lines expressing PAM-1 mutants that mimic (TS/DD) or prevent (TS/AA) phosphorylation at these sites were studied. PAM-1 TS/AA yields a lumenal monooxygenase domain that enters secretory granules inefficiently and is rapidly degraded. In contrast, PAM-1 TS/DD is routed to regulated secretory granules more efficiently than wild-type PAM-1 and monooxygenase release is more responsive to secretagogue. Furthermore, this acidic cluster affects exit of internalized PAM-antibody complexes from late endosomes; internalized PAM-1 TS/DD accumulates in a late endocytic compartment instead of the trans-Golgi network. The increased ability of solubilized PAM-1 TS/DD to aggregate at neutral pH may play an important role in its altered trafficking.
nals involved in sorting the membrane proteins that function in secretory granules have not been well defined. Even the relative importance of granule entry signals versus signals for removal of non-granule membrane proteins is not clear. Peptidylglycine ␣-amidating monooxygenase (PAM; EC 1.14.17.3), a bi-functional enzyme involved in the ␣-amidation of peptides (3, 4) , is a type I integral membrane protein processed and stored in secretory granules. Many type I membrane proteins use signals in their COOH terminus to control trafficking (5) (6) (7) (8) (9) , and the COOH terminus of PAM contains several distinct trafficking signals (10, 11) .
The role of phosphorylation as a routing determinant for membrane proteins has been well established (8, (12) (13) (14) . In particular, phosphorylation of acidic clusters in the cytosolic domains of proteins such as furin (6, 15) , carboxypeptidase D (16) , and prohormone convertase 6B (17) plays a crucial role in trafficking. For furin, the binding of both adaptor protein 1 (AP-1) and phosphofurin acidic cluster sorting protein 1 (PACS-1) is increased by casein kinase II (CKII)-catalyzed phosphorylation of Ser residues located within an acidic cluster ( Fig. 1A) (18, 19) . In the cytosolic domain of PAM, the region located between Lys 953 and Lys 971 is extremely acidic, forming a PEST motif, with Thr 959 and Ser 961 identified as potential phosphorylation sites (NetPhos 2.0 Prediction, Center for Biological Sequence Analysis, www.cbs.dtu.dk/services/). However, truncation of PAM-1 at Ser 961 , which interrupts the acidic cluster, yields a protein that is trafficked normally (20) . Therefore, the phosphorylation of an acidic cluster has not been demonstrated to be important in PAM trafficking.
When membrane PAM is expressed in the neuroendocrine cell line, AtT-20, it is efficiently cleaved in the secretory pathway to yield soluble peptidylglycine ␣-hydroxylating monooxygenase (PHM) and membrane peptidyl-␣-hydroxyglycine ␣-amidating lyase (PAL). Although intact membrane PAM exhibits both enzymatic activities, soluble PHM has a turnover number severalfold higher than intact PAM, revealing a regulatory role for the COOH-terminal regions of PAM (21) . The majority of membrane PAM and PAL accumulates in a distal region of the trans-Golgi network (TGN) at steady state, although some of the protein is located in secretory granules (22) . The small amount of PAM expressed on the surface of AtT-20 cells at steady state undergoes rapid internalization and is recycled to the TGN via perinuclear endosomes. The internalized protein may undergo lysosomal degradation or be packaged into new granules (11, 23, 24) .
PAM is phosphorylated on multiple residues in its cytosolic COOH-terminal domain (CD) (10) . Test tube assays utilizing recombinant PAM-CD were used to determine that protein kinase A phosphorylates Ser 921 and protein kinase C phosphorylates Ser 932 and Ser 937 (10 limits the secretion of soluble PHM and increases the turnover rate of newly synthesized PAM-1 (11) . Furthermore, phosphorylation of PAM-1 at Ser 937 directs the protein away from lysosomes after internalization from the cell surface, whereas dephosphorylation of this site is needed for a later step in the endocytic pathway (10, 11) . The novel protein kinase, PAM cytosolic interactor protein-2 (P-CIP2), selectively phosphorylates Ser 949 in the CD of PAM (25) . P-CIP2 interacts with the CD of PAM at several sites that are closer to the transmembrane domain than Ser 949 (25) . Mutation of the PAM-CD at these juxtamembrane sites eliminates the ability of PAM to bind tightly to P-CIP2 and eliminates the ability of PAM to modify regulated secretion (26) . These mutations do not eliminate the ability of PAM to be phosphorylated by P-CIP2 (25) . Since Ser 949 lies within a fairly acidic region of the PAM-CD (Fig. 1) , this raised the possibility that this region functions as an acidic cluster in PAM trafficking. Therefore, our goals were to identify sites where CKII phosphorylates the CD of PAM and to determine whether these sites could be involved in mediating PAM trafficking. In this study, we identified Thr 946 
MATERIALS AND METHODS

In Vitro Phosphorylation of Purified Recombinant PAM COOH-ter-
minal Domain-Purified, recombinant rat PAM-CD (Met-Ala-Ser-MetThr-Gly-Gly-Gln-Gln-Met-Gly-Arg-Ile-Pro-rPAM-1(898 -976)) (40 g) was incubated with 0.4 g of CKII from sea star, Pisaster ochraceus (Upstate Biotechnology, Inc.), in 20 mM HEPES, 10 mM MgCl 2 (pH 7.0) buffer containing 10 mM ATP and 100 Ci of [␥-32 P]ATP for 2 h (37°C). The reaction was stopped by adding 0.1% trifluoroacetic acid, and the peptide was bound to a C 18 SepPak cartridge, washed with 0.1% trifluoroacetic acid, and eluted with 80% acetonitrile, 0.1% trifluoroacetic acid. The dried eluate was redissolved in 25 mM Tris-HCl, 1 mM EDTA (pH 8.5) and digested with endoproteinase LysC (2.0 g; Roche Molecular Biochemicals) for 18 h at 37°C. The lyophilized sample was applied to a series of Bio-Sil TSK-DEAE (Bio-Rad) columns equilibrated and eluted in 32% acetonitrile, 0.1% trifluoroacetic acid. The single major peak of labeled material included in the column was pooled and dried before application to a Bio-Sil TSK-DEAE column equilibrated in 50 mM sodium acetate (pH 4.5) containing 30% acetonitrile. This column was eluted with a linear gradient of 0.25 M NaCl, 50 mM sodium acetate (pH 4.5), and 30% acetonitrile. The phosphopeptides were pooled and dried before desalting on the Bio-Sil TSK-DEAE columns. The labeled Bio-Sil TSK-DEAE eluates were covalently linked to arylamine membranes (Sequelon-AA; Waters Instruments) for Edman degradation sequencing in an ABI model 477A instrument. The sequencer was configured to divide the successive phenylthiohydantoin fractions, 40% for on-line high pressure liquid chromatography detection, and 60% for determination of 32 P radioactivity by liquid scintillation counting. Expression Vectors-pBluescript plasmids encoding either PAM-1  with Thr  946 and Ser  949 mutated to Ala  946 and Ala  949 or to Asp  946 and  Asp  949 were made using SOEing polymerase chain reaction (27) . Amplification for both constructs involved an upstream sense primer (rPAM-1(2954 -3250)) and mutagenic antisense primers with codons (underlined) either for Ala 946 and Ala 949 (5Ј-GCCCCCTCTGCGCT-CACTCGG -3Ј) or for Asp 946 and Asp 949 (5Ј-CATCCCCTCGTCGCT-CACTCGG-3Ј) and mutagenic sense primers for Ala 946 and Ala 949 (5Ј-GAGCGCAGAGGGGGCTGACCAAGAG-3Ј) or for Asp 946 and Asp
949
(5Ј-GAGCGACGAGGGGGATGACCAAGAG-3Ј) and T7 antisense primers. pBS.KrPAM-1 TS/AA and pBS.KrPAM-1 TS/DD were both made by inserting the final respective amplified fragment into pBS.KrPAM-1 using the restriction enzymes HindIII and XmaI. The DNA regions derived from polymerase chain reaction were verified by sequencing. Constructs were placed into the pCI.neo mammalian expression vector (Promega Corp.) using SalI and NotI cloning sites.
Transfection and Generation of Stable Cell
Lines-AtT-20 cells were transfected using Lipofectin (Sigma) with either pCI.neo.KrPAM-1/ T946A/S949A (TS/AA) or pCI.neo.KrPAM-1/T946D/S949D (TS/DD) (10, 11) . The stably transfected AtT-20 cell lines were maintained in Dulbecco's modified Eagle's medium/F-12 medium (Life Technologies, Inc.) with 10% fetal clone serum (HyClone, Logan, UT), 10% NuSerum (Collaborative Research, Bedford, MA), and antibiotics. Medium containing 0.5 mg/ml G418 was used for selection and maintenance of transfected cells. Three clones from each cell line were examined, with the levels of PAM expression not varying more than 2-fold. Assays for PHM and PAL in medium and cell extracts were performed as described (11) .
Antibodies-The following rabbit polyclonal antisera were diluted 1:1000 for use in immunostaining and Western blot analyses: PHM (JH1764) directed against PAM-1(37-382); exon A (JH629) directed against PAM-1(409 -497); and PAL (JH 471) directed against PAM-1(463-864) (11, 22) . The following monoclonal antibody was used, syntaxin 6 (BD Transduction Laboratories, 1:500).
Generation of Phospho-Ser 949 Antibody-A peptide, Asp
942
-Arg-ValSer-Thr-Glu-Gly-(P)Ser 949 -Asp-Gln-Glu-Lys 953 ( Fig. 1, italics) , from the cytosolic domain of PAM was synthesized with an NH 2 -terminal Cys residue using monobenzyl-protected Fmoc (N-(9-fluorenyl)methoxycarbonyl) phospho-Ser. The peptide was purified as a monomer and conjugated to keyhole limpet hemocyanin (Pierce) with glutaraldehyde or with maleimidobenzoyl-N-hydrosysuccinimide ester. Two rabbits were immunized by Covance (Denver, PA) using an equal mixture of the two conjugates. Serum (JH2541) was depleted of antibody against the nonphosphorylated PAM-1(942-953) peptide by incubation with Affi-Gel 10 to which non-phosphorylated peptide had been linked. The titer and specificity of the P-Ser 949 antibody (JH2541) were determined with a solid phase assay using the synthetic peptides PAM-1(942-953) and PAM-1(942-953)P-Ser
949
. The depleted phosphoserine specific antibody, JH2541, was used at a dilution of 1:250.
Immunofluorescence Microscopy-Immunofluorescence microscopy was performed as described previously using 4% paraformaldehyde or 100% methanol (24) . For experiments with the microtubule destabilizing drug, nocodazole (Sigma), cells were plated on poly-L-lysine-coated glass slides and grown for 36 h before incubation for 20 min in complete serum-free medium (CSFM) (37°C). The cells were then incubated in CSFM containing 10 M nocodazole for 20 min (37°C) before fixation in 100% ice-cold methanol. Following fixation, the cells were blocked with 2 mg/ml bovine serum albumin in phosphate buffer, before incubation with the exon A and syntaxin 6 antibodies. Visualization was done using a Cy3-conjugated donkey anti-mouse IgG and a fluorescein isothiocyanate-conjugated goat anti-rabbit IgG. Cells were observed under epifluorescence optics on a Zeiss Axioskop (Carl Zeiss Inc., Thornwood, MT). Cells were photographed and analyzed with a Princeton Instruments Micromax digital camera.
Antibody Internalization and the Microtubule-destabilizing Drug, Nocodazole-Antisera to PAL or exon A (JH471 or JH629; diluted 1:50) were used as described (11, 24, 28) . Briefly, cells were incubated with antiserum at different temperatures (4, 20, or 37°C) and chased in antibody-free CSFM without sodium bicarbonate (CSFM-Air) for various lengths of time to trap the internalized PAM-antibody complexes in either early or late stages of internalization (29) . Nocodazole was dissolved in CSFM-Air and used at a concentration of 10 M. After incubation with exon A antiserum (1:50), for 1 h at 20°C to load early and late endosomes with PAM-antibody complexes, cells were rinsed in antibody-free CSFM, warmed to 37°C, and incubated with 10 M nocodazole for 60 min before fixation and double immunostaining with the syntaxin 6 monoclonal antibody.
Antibody Internalization Utilizing the Protein Kinase Inhibitor, DRB-The CKII inhibitor, 5,6-dichloro-1-␤-D-ribofuranosylbenzimidazole (DRB; Calbiochem) (30) , was dissolved in CSFM-Air. AtT-20 PAM-1 cells were incubated with exon A antiserum for 30 min (20°C) to load early and late endosomes with PAM-antibody complexes before the addition of 100 M DRB to the medium (30 min; 20°C). The medium was then replaced with 37°C antibody-free CSFM-Air containing 100 M DRB for either 30 or 60 min before fixation and immunostaining.
Stimulated Secretion-Stably transfected AtT-20 cells were plated in triplicate on poly-L-lysine-coated culture plates. Prior to the experiment, cells were incubated in three changes of CSFM-Air over 1.5 h. Basal collections of medium were for 30 min each; these were followed by one 30-min collection in the presence of 1 mM BaCl 2 (31) . Collected medium was centrifuged after addition of protease inhibitors. Cells were extracted in 20 mM sodium N-tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid, 10 mM mannitol, and 1% Triton X-100 (pH 7.4). To measure PHM activity, aliquots of medium or cell extracts were assayed using 0.5 M CuSO 4 , 0.5 mM ascorbate, 0.5 M Ac-Tyr-Val-Gly, trace amounts of 125 I-labeled Ac-Tyr-Val-Gly, 0.1 mg/ml catalase, and 150 mM NaMES (pH 5.5) (32, 33) .
PAM-1 Extraction and Sucrose Gradient Sedimentation-One confluent well of a 6-well dish from each of the three stably transfected AtT-20 cell lines was grown for 2 days before preincubation in 500 l of CSFM-Air for 5 min (37°C). The cells were then incubated on ice in ice-cold buffer (20 mM PIPES, 2 mM Na 2 EDTA, 50 mM NaF, 10 mM Na 4 P 2 O 7 and 1 mM Na 3 VO 4 , pH 7.5) with protease inhibitors (30 g/ml phenylmethylsulfonyl fluoride, 2 g/ml leupeptin, 2 g/ml pepstatin, 16 g/ml benzamidine, 5 g/ml lima bean trypsin inhibitor) and 1% Triton X-100 (500 l) added (15 min) (31) . A suspension of the scraped cells was centrifuged at 250,000 ϫ g for 20 min (4°C). Aliquots (200 l) from the supernatant of each cell type were further fractionated on 2 ml of 5-20% linear sucrose gradients buffered to pH 7.5 or pH 5.5 with the PIPES buffer minus detergent. A 50% sucrose "pad" (169 l) was placed at the bottom of each gradient, and the following molecular weight markers (50 -250 g) were used as internal standards: cytochrome c, ovalbumin, bovine serum albumin, catalase, and apoferritin (Sigma). Gradients were centrifuged in a Ti-55 swinging bucket rotor in a TL-100 centrifuge (Beckman Instruments) for 5 h (4°C) at 50,000 rpm (214,000 ϫ g). Fractions (169 l) from each gradient were collected from the top to the bottom and particulate matter at the bottom of the gradient was resuspended in Laemmli sample buffer. Gradient fractions were analyzed by Western blot using the exon A antibody, and molecular weight markers were visualized using Coomassie Brilliant Blue R-250.
Cell Extract Immunoprecipitation and Western Blot Analysis-A 100-mm dish of confluent AtT-20 PAM-1 cells was extracted as described above (31) , and a suspension of the scraped cells was centrifuged at 304,000 ϫ g for 20 min (4°C). Aliquots (200 l) from the supernatant were incubated with 10 l of the exon A antibody or the P-Ser , cells were metabolically labeled, and pulse-chase experiments were performed (10, 11, 24, 35) . Ice-cold 20 mM sodium N-tris[hydroxymethyl]methyl-2-aminoethanesulfonic acid, 10 mM mannitol, and 1% Triton X-100 (pH 7.4) buffer with protease inhibitors plus protein phosphatase inhibitors (5 mM EGTA, 5 mM EDTA, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate and 50 mM NaF) was used for cell extraction. Immunoprecipitates were prepared as described (10, 24) . Films were analyzed using Scion Image (Scion Corp.).
In Vitro Kinase Assay-Phosphorylation of recombinant PAM-CD was carried out as described (25) . The reaction volume was 30 l and consisted of the following reagents: kinase buffer (50 mM HEPES, 1 mM MgCl 2 (pH 7.5), 0.1% Thesit); 5 g of recombinant PAM-CD; Ϯ 100 M DRB; purified recombinant P-CIP2, CKII (Calbiochem), or protein kinase A (Calbiochem); and 1 or 2 Ci of [␥-
32 P]ATP (3000 Ci/mmol, Amersham Pharmacia Biotech). Reactions were incubated at 37°C for 30 or 60 min, fractionated by SDS-PAGE (15% polyacrylamide), transferred to Immobilon-P membranes, and visualized by autoradiography. 946 and Ser 949 by Casein Kinase II-Since acidic clusters often play a crucial role in the trafficking of membrane proteins and may serve as sites for phosphorylation by CKII, we wanted to determine whether the cytosolic domain of PAM is a substrate for CKII. Purified recombinant PAM-CD incubated with [␥-32 P]ATP and sea star CKII underwent phosphorylation primarily on Ser residues (data not shown). To identify the phosphorylation sites(s), endoproteinase LysC-digested samples were subjected to gel filtration. The single major peak observed was then applied to an anion exchange high pressure liquid chromatography resin, yielding two major peaks, A and B (Fig.  1B) . Edman degradation of each peak yielded NH 2 -terminal FIG. 1. In vitro phosphorylation of PAM-1 with CKII. A, the sequences of the cytosolic, COOH-terminal domains of rat (RPAM; GenBank TM / EBI accession number P14925) and Xenopus (XPAM; GenBank TM /EBI accession number S17855) PAM, mouse cation-dependent mannose 6-phosphate receptor (MCDM6PR; GenBank TM /EBI accession number P24668), human furin (HFUR; GenBank TM /EBI accession number KXHUF), mouse prohormone convertase 6B (MPC6B; GenBank TM /EBI accession number BAA04507), and human carboxypeptidase D (HCPD; GenBank TM / EBI accession number NP001295) were aligned based on their acidic clusters (identified in bold) using ClustalW multiple sequence alignment (BCM Search Launcher). Gap opening penalty was set at 10, and the Gap extension penalty was 0.05. Tyr or Phe residues of importance in trafficking are indicated by Y or F, respectively. Known phosphorylated residues are shaded. The peptide to which the P-Ser 949 -specific antibody was raised is shown in italics in RPAM. B, recombinant PAM-CD phosphorylated by purified sea star CKII was digested with endoproteinase LysC, and peptides were fractionated by gel filtration. The single peak of radioactivity was pooled and fractionated on a Bio-Sil TSK-DEAE column. C, pools A and B were subjected to Edman degradation with 60% of each phenylthiohydantoin fraction counted for 32 (Fig. 1C) . To investigate the role of phosphorylation at these two sites, vectors encoding PAM-1 in which both residues were mutated to Ala (PAM-1 TS/AA) or to Asp (PAM-1 TS/DD) were created and individually transfected into AtT-20 cells.
RESULTS
Recombinant PAM-CD Is Phosphorylated on Thr
PAM-1 TS/AA and PAM-1 TS/DD Mutants Display an Altered Steady-state Localization-
The steady state localization of each mutant PAM-1 protein in AtT-20 cells was compared with that of PAM-1. As shown previously, wild-type PAM-1 was localized in the perinuclear region of the cell ( Fig. 2A, top panel, wide arrows) in a compact structure identified as the TGN on the basis of immunoelectron microscopy (11, 22, 26) . Slight staining at the tips of the AtT-20 PAM-1 cells (narrow arrows) was also observed. Immunostaining in the PAM-1 TS/AA cells ( Fig. 2A, middle panel) was only subtly different, with signal observed in the perinuclear region (wide arrow) along with more diffuse vesicular staining throughout the cell and more readily detectable staining at the tips of processes (narrow arrows). However, in the PAM-1 TS/DD cells ( Fig. 2A, bottom  panel) , immunostaining for PAM was clearly more widely distributed, with vesicular structures observed at the tips of the processes (narrow arrows) along with intense staining of what generally appeared to be more diffuse structures in the perinuclear region (wide arrows). Thus, PAM-1 TS/DD has a unique steady-state localization in AtT-20 cells.
Since the TGN and late/recycling endosomes are both localized in the perinuclear region and cannot be distinguished immunocytochemically (36), we used nocodazole, a microtubule-destabilizing drug that causes dispersal of the late/recycling endosomes from the TGN and the eventual dispersal of the TGN, to compare the three proteins (37) (38) (39) . The effects of nocodazole on the TGN depend on drug dosage, time of treatment, the marker protein analyzed, and cell type (40 -42) . Consistent with its demonstrated localization to the TGN, much of the PAM-1 was still localized to a compact structure in the perinuclear region following a short, low-dose incubation with nocodazole for 20 min (Fig. 2C, top panel, wide arrows) . A similar structure was also visualized by antisera to two TGN markers, syntaxin 6 and TGN38 (Fig. 2B, wide arrows) (43, 44) . Staining for syntaxin 6, which is localized to a discrete region of the TGN, was not affected by this nocodazole treatment (Fig.  2B , top panels, wide arrows). However, following treatment of the AtT-20 PAM-1 cells with nocodazole, staining for TGN38 was localized to distinct vesicular structures (Fig. 2B, bottom  panel, narrow arrows) . Furthermore, nocodazole treatment did increase PAM staining in vesicular structures distributed throughout the cells (Fig. 2C, top panel, narrow arrow) , and this effect increased with a longer nocodazole treatment time (data not shown).
Nocodazole treatment affected PAM-1 TS/AA cells in much the same way it affected the PAM-1 cells. Some PAM-1 TS/AA remained in the perinuclear area (Fig. 2C , middle panel, wide arrows), coincident with syntaxin 6 (data not shown), and PAM-1 TS/AA staining increased in vesicular structures dispersed throughout the cell (Fig. 2C , middle panel, narrow arrows). In contrast, nocodazole treatment brought about a dramatic alteration in the localization of PAM-1 TS/DD. Although syntaxin 6 staining was unaffected (data not shown), little perinuclear staining for PAM-1 TS/DD was observed following nocodazole treatment (Fig. 2C, bottom panel, wide arrow) . Broadly distributed PAM-1 TS/DD-containing vesicles were present throughout the cell, with staining apparent in the processes and along the margins of the cells (Fig. 2C, 3Ϫ -labeled cell extracts (Fig. 3A, 120 kDa) . The mutation of these two potential phosphorylation sites did not eliminate the phosphorylation of PAM, with similar ratios of 32 Plabeled to 35 S-labeled protein observed for PAM-1 and for PAM-1 TS/DD. Therefore, the phosphorylation of Thr 946 and/or Ser 949 accounts for only a small fraction of PAM phosphorylation at steady state.
To determine if Ser 949 in the PAM-CD is phosphorylated in vivo, a polyclonal antibody specific for P-Ser 949 was generated ( Fig. 1, italics) . After depleting the P-Ser 949 serum of antibody against non-phosphorylated PAM-1(942-953), a solid phase assay demonstrated that the antiserum recognized peptide phosphorylated at Ser 949 but exhibited no cross-reactivity with the non-phosphorylated peptide or with PAM-1(942-953)P-Thr 946 / P-Ser 949 . The specificity of the P-Ser 949 antiserum was examined further by immunostaining (Fig. 3B) and Western blot analysis (Fig. 3C ) of cells expressing PAM-1, PAM-1 TS/AA, or PAM-1 TS/DD. AtT-20 PAM-1 cells immunostained with the P-Ser 949 antiserum exhibited staining in a compact, perinuclear region (Fig. 3B, 1st panel, wide arrows) that corresponded to immunostaining with the syntaxin 6 antibody (data not shown). Only a small amount of P-Ser 949 -specific staining was observed at the tips of the PAM-1 cells (Fig. 3B, 1st panel,  narrow arrows) . Importantly, no signal was observed in PAM-1 TS/AA cells (Fig. 3B, middle panel) . Thus, the P-Ser 949 antibody can be used to demonstrate that a fraction of PAM-1 is phosphorylated at Ser 949 in AtT-20 cells. To our surprise, the P-Ser 949 antiserum visualized PAM-1 TS/DD, with staining observed in the perinuclear region and tips of the cells (Fig. 3B, 3rd panel, wide and narrow arrows) , as observed with the PHM antibody (Fig. 2C) . It is not unprecedented for a phosphopeptide-specific antibody to recognize an aspartate-substituted peptide. Previously, we demonstrated that another PAM-1-specific P-Ser antibody (P-Ser 937 ) detected PAM-1 in which Ser 937 was replaced by Asp 937 (11) . Overall, these data suggest that the P-Ser 949 antibody recognizes a conformation imparted by the negative charge present at position 949 rather than the presence of P-Ser 949 . For a final test of antibody specificity, extracts of PAM-1, PAM-1 TS/AA, and PAM-1 TS/DD cells were analyzed by Western blot. Intact 120-kDa PAM and 70-kDa membrane PAL were detected in all three cell lines with the PAL antibody (Fig.  3C) . The P-Ser 949 antiserum also detected intact PAM and membrane PAL in the PAM-1 and PAM-1 TS/DD cells. The P-Ser 949 antiserum did not detect PAM-1 TS/AA. Thus, the P-Ser 949 antiserum has the required specificity to establish that PAM-1 is phosphorylated on Ser 949 in AtT-20 cells. The P-Ser 949 antiserum was used to evaluate the extent to which Ser 949 on the PAM-CD is phosphorylated. Intact 120-kDa PAM-1 and 70-kDa membrane PAL were detected with the exon A antibody in the supernatant (input) produced from extracted PAM-1 cells centrifuged at 304,000 ϫ g and from immunoprecipitates with the exon A and P-Ser 949 antibodies (Fig. 3D) . By using Scion Image for quantitation, we were able to determine that less than 5% of the 120-kDa PAM-1 and 70-kDa PAL are phosphorylated on Ser 949 .
PHM Produced from PAM-1 TS/AA and PAM-1 TS/DD Is Active and Varies in Its Responsiveness to a Secretagogue-
Enzyme assays and Western blots were used to compare protein expression in the different cell lines. Extracts of AtT-20 PAM-1, PAM-1 TS/AA, and PAM-1 TS/DD cells were assayed for PHM activity, and aliquots containing equal units of PHM activity (150 pmol/h) were compared (Fig. 4A) . PAL produced from each cell line was also analyzed and determined to be active (data not shown). While both enzymatic domains of PAM-1 are catalytically active, endoproteolytic cleavages that release monofunctional PHM from membrane PAM result in an increase in the turnover number of the monooxygenase (45) . The PHM antibody identified 120-kDa PAM-1 and 45 kDa PHM in all three cell lines, whereas the PAL antibody detected 120-kDa PAM-1 and 70-kDa PAL. Similar amounts of 120-kDa PAM-1, 70-kDa PAL, and 45-kDa PHM were observed for the PAM-1 and PAM-1 TS/DD cells. In contrast, the products generated from 120-kDa PAM-1 TS/AA were distinctly different; less 70-kDa PAL was present, and processing of 120-kDa PAM-1 TS/AA into monofunctional PHM was more extensive. The total amount of protein detected by the PHM antiserum in antiserum. An input sample and the immunoprecipitates (IPT) were fractionated on a 4 -15% SDS gel and analyzed by Western blot using the exon A antibody. The percentage of the total extract loaded on the gel is shown.
the PAM-1 TS/AA extract was reduced, suggesting that PHM produced from PAM-1 TS/AA has a higher specific activity than PHM produced from PAM-1 or PAM-1 TS/DD. Elucidation of the underlying mechanism will require an analysis of intact PAM-1 TS/AA and the monofunctional PHM produced from it.
The expression of PAM-1 is known to alter the ability of AtT-20 cells to store soluble proteins in secretory granules, perhaps through the interaction of PAM-1 with cytosolic proteins that regulate the actin cytoskeleton (26, 46) . Since entry into secretory granules is essential for regulated secretion, we quantified the basal and BaCl 2 -stimulated secretion of PHM activity from the three cell lines (Fig. 4B) . Secretion of PHM activity is stimulated 1.8-fold in PAM-1 and PAM-1 TS/AA cells but 3.1-fold in PAM-1 TS/DD cells. Overall, these data demonstrate that the PAM-1 TS/DD cells are able to store the mutant PAM protein in regulated secretory granules to a greater extent than either the PAM-1 or the PAM-1 TS/AA cells.
The PAM-1 Thr 946 /Ser 949 Sites Affect PAM-1 Degradation and Storage-The metabolism of PAM-1 TS/AA and PAM-1 TS/DD was compared with that of PAM-1 using pulse/chase metabolic labeling and an antibody specific for PHM. As expected, a 117-kDa PAM protein was immunoprecipitated from extracts of all three cell lines following the pulse (Fig. 5A, 0 h) . In all three cell lines, the newly synthesized 117-kDa protein increased in size to 120 kDa during the 1-h chase, presumably due to oligosaccharide maturation (10, 23, 28) . A paucity of methionine residues in PAL (only 6 of the 26 Met residues in PAM-1 are in 70-kDa PAL) makes its detection during chase incubations difficult, so quantification is based on the immunoprecipitation of PHM (11) .
Newly synthesized 120-kDa PAM-1 is cleaved to 45-kDa PHM only after it enters immature secretory granules (24) . As shown previously, 45-kDa PHM was first detected in AtT-20 PAM-1 cells following the 2-h chase, with more 45-kDa PHM present after the 4-h chase (Fig. 5A, 1st panel) (11) . Similarly, 45-kDa PHM was first detected in the PAM-1 TS/AA cells after the 2-h chase (Fig. 5A, middle panel) . In contrast, in the PAM-1 TS/DD cells, cleavage of 120-kDa PAM-1 to 45-kDa PHM was detected earlier, following the 1-h chase, suggesting enhanced access of the mutant protein to the cleavage competent compartment (Fig. 5A, last panel) . Whereas newly synthesized 45-kDa PHM accumulated in the medium of PAM-1 and PAM-1 TS/DD cells during the 4-h chase, very little newly synthesized 45-kDa PHM was secreted from the PAM-1 TS/AA cells.
Pulse/chase metabolic labeling followed by quantitative immunoprecipitation of cell extracts and media allows one to quantify both secretion and turnover. We quantified the amount of radiolabeled PAM protein recovered after the 4-h chase; although approximately two-thirds of the newly synthesized protein was recovered from the PAM-1 and PAM-1 TS/DD cells, only one-third was recovered from the PAM-1 TS/AA cells (Fig. 5B, p Յ 0.05) . The amount of newly synthesized 120-kDa PAM protein remaining in the cells after 4 h was similar in the PAM-1 and PAM-1 TS/DD cells (Fig. 5C, open bars) . In contrast, the PAM-1 TS/AA cells contained little intact PAM-1 after the 4-h chase (p Յ 0.04). The 45-kDa PHM generated from PAM-1 can be stored (Fig. 5C, hatched bars) or secreted ( that PAM-1 aggregates more at pH 5.5 than at pH 7.5 (57) . In this simplified single compartment system, the juxtamembrane domains of PAM play a key role in its aggregation. Therefore, we compared the pH-dependent aggregation of solubilized PAM-1, PAM-1 TS/AA, and PAM-1 TS/DD using linear sucrose gradients at pH 7.5 to mimic conditions in the Golgi and at pH 5.5 to mimic conditions in the lumen of mature secretory granules (58 -60) .
At pH 7.5 ( Fig. 6A) , PAM-1 fractionated as expected based on its monomeric molecular weight of 120,000; only 6% of the total intact PAM-1 was recovered from the bottom of the gradient (particulate matter). At pH 5.5, 17% of the intact PAM-1 sedimented to the bottom of the gradient. In comparison, almost none (1.7%) of the intact PAM-1 TS/AA pelleted at pH 7.5, whereas 41% pelleted at pH 5.5 (Fig. 6B) . Most strikingly, 11% of the intact PAM-1 TS/DD was recovered from the bottom of the gradient at pH 7.5, whereas 13% of the intact PAM-1 TS/DD was pelleted at pH 5.5 (Fig. 6C) . The increased ability of PAM-1 TS/DD to aggregate at neutral pH could facilitate its entry into immature secretory granules, whereas the inability of PAM-1 TS/AA to aggregate at pH 7.5 could result in its exclusion from secretory granules and its trafficking to degradative pathways. If the behavior of PAM-1 TS/DD mimics the effects of phosphorylation at this site, pH-dependent aggregation and secretory granule entry may be facilitated by phosphorylation.
AtT-20 PAM-1 TS/AA and PAM-1 TS/DD Cells Have Distinct Internalization
Phenotypes-The internalization of antibodies directed against a lumenal domain of PAM was used to assess endocytic trafficking in the PAM-1 TS/AA and PAM-1 TS/DD cells (11, 20) . We manipulated temperature as a simple way to halt the internalized PAM-antibody complexes in specific cellular compartments. At 4°C, PAM-antibody complexes remain on the cell surface, and internalization is blocked (29) . Raising the temperature to 20°C allows entry of the PAMantibody complexes into both early and late endosomes. As shown in Fig. 7 , A-C, all three cell types had similar immunostaining profiles when the temperature was raised to 20°C, FIG. 6 . Sucrose gradient sedimentation of PAM-1 and mutant PAM-1 extracts. AtT-20 PAM-1 (A), PAM-1 TS/AA (B), and PAM-1 TS/DD (C) cells were extracted in buffer with protease inhibitors and 1% Triton X-100 (pH 7.5) and centrifuged at 250,000 ϫ g at 4°C. Aliquots (200 l) of this supernatant were further fractionated on 5-20% linear sucrose gradients buffered either to pH 7.5 or pH 5.5 with 50% sucrose "pads" placed at the bottom of the gradients. Fractions were collected from the top of the gradients down, with the pellet (P) fraction solubilized from the bottom of each gradient. Western blot analysis of the fractions was done using the exon A antibody; only the 120-kDa region of the blot is shown. Marker proteins of known Svedberg value and native molecular weight (81) were analyzed at the same time as follows: cytochrome c (12.6 kDa, 1.8 S), ovalbumin (44 kDa, 3.6 S), bovine serum albumin (66 kDa, 5 S), catalase (250 kDa, 11.4 S), and apoferritin (450 kDa, 17.6 S). B and C, data from 4 to 5 experiments were quantified using Scion Image. Since the amount of labeled 120-kDa PAM protein often increased during the 1st h of chase, the amount of newly synthesized PAM-1 protein present after the 1-h chase was set to 100%. B, the total recovery of PAM protein after the 4-h chase was determined by adding the amount of 120-kDa protein in the cell extract to the total amount of 45-kDa PHM present in both the cell extract and medium. C, total recovery of 120-kDa PAM and 45-kDa PHM in the cell extract (cell) and medium (mdm) is shown.
with large vesicular structures present in the processes and tips of the cells (narrow arrows) and in the perinuclear region (wide arrows).
Internalization steps beyond this point were then examined (Fig. 7, D-I ). Cells were incubated with PAL antibody at 20°C for 60 min to load both early and late endocytic compartments with PAM-antibody complexes; as expected, no differences were apparent (data not shown). Cells were then chased in antibody-free medium at 37°C, permitting the complexes to move out of the endocytic compartments. Distinct internalization profiles were observed for all three cell types. In AtT-20 PAM-1 cells, a 30-min chase at 37°C allowed efficient collection of the internalized PAM-antibody complexes in the perinuclear TGN region (Fig. 7D, wide arrow) with only a few large vesicular structures remaining spread throughout the cell body and processes (Fig. 7D, narrow arrow) . Fewer vesicular structures were present following the 60-min chase (Fig. 7G) .
The staining profile in the PAM-1 TS/AA cells was, however, very different from that in the PAM-1 cells (Fig. 7, E and H) . Large immunostained vesicular structures remained spread throughout the cell with a heavy concentration in the processes and tips (narrow arrows), following both the 30-and 60-min chases. Furthermore, the intensity of the signal decreased substantially following the 60-min chase, suggesting that degradation or recycling of the PAM-1 TS/AA-antibody complexes to the cell surface had occurred. The PAM-1 TS/DD cells (Fig. 7F) exhibited an intermediate staining pattern after the 30-min chase at 37°C, with large vesicular structures still spread throughout the cellular processes and tips (narrow arrows) and some accumulation of complexes in the perinuclear region (wide arrow). This trend toward collection in the perinuclear region (wide arrows) continued following the 60-min chase, yet a significant number of vesicular structures remained spread throughout the cells (Fig. 7I, narrow arrows) . Overall, these data suggest that both phosphorylation and dephosphorylation of Thr 946 and/or Ser 949 play key roles in routing to the perinuclear region from late endosomes. Neither modification seems to play a key role earlier in the endocytic pathway.
Internalized PAM-1 TS/DD Is Not Recycled to the TGNSince the bulk of the internalized PAM-antibody complexes recycle to the perinuclear region in both the PAM-1 and PAM-1 TS/DD cells, we again used nocodazole to distinguish between PAM-antibody complexes that had recycled to the TGN (short incubation time, low-dose nocodazole-insensitive) versus PAMantibody complexes that remained in the late/recycling endosomes (nocodazole-sensitive) (22, 37, 38) . Both the TGN and late/recycling endosomes localize to the perinuclear region (36) .
AtT-20 PAM-1 and PAM-1 TS/DD cells were incubated with exon A antibody, and PAM-antibody complexes were internalized for 60 min at 20°C to load the early and late endocytic compartments while preventing exit from the late endocytic compartments (Fig. 8, A-D) . Nocodazole was introduced only after the first incubation with antibody, since it can inhibit the maturation of endosomes (61, 62) . The cells were then incubated with 10 M nocodazole in antibody-free CSFM-Air for 60 min (Fig. 8) at 37°C. In the PAM-1 cells, a significant fraction of the internalized PAM-antibody complexes co-localized with the syntaxin 6 marker (Fig. 8, A and B, wide arrows) , indicating that this dose of nocodazole in AtT-20 cells still allowed proteins to move from late endosomes to the TGN. Small vesicular structures remained spread throughout the nocodazoletreated PAM-1 cells (Fig. 8A, narrow arrows) , suggesting that nocodazole is retarding trafficking from late endosomes to the TGN. In the PAM-1 TS/DD cells, only a small fraction of the internalized PAM-antibody complexes co-localized with the syntaxin 6 marker after the 1-h chase; instead, the PAMantibody complexes remained in distinct punctate structures spread throughout the cells including the processes and tips. These data suggest that PAM-1 TS/DD remains in the more nocodazole-sensitive late or recycling endosomes and cannot DRB Prevents Internalized PAM-1 from Recycling to the TGN-To understand better the trafficking steps affected by the phosphorylation of Thr 946 and/or Ser 949 , we looked for pharmacological agents that could be used on intact cells. To this end, the effectiveness of the CKII inhibitor, DRB, was first evaluated in test tube assays using recombinant PAM-CD protein (Fig. 9A) . When tested at 100 M, DRB effectively reduced the CKII-mediated phosphorylation of recombinant PAM-CD to ϳ38% of the control. However, DRB proved to be an even more potent inhibitor of P-CIP2, a kinase endogenous to AtT-20 cells that phosphorylates PAM at Ser 949 , reducing the phosphorylation of recombinant PAM-CD to 5.6% of the control (25) . Finally, protein kinase A-mediated phosphorylation of recombinant PAM-CD was reduced to ϳ59% of the control by 100 M DRB.
If a DRB-sensitive protein kinase (P-CIP2, CKII, etc.) is involved in the endocytic trafficking of PAM, its role should be most apparent as proteins move out of late endosomes. To test this possibility, control AtT-20 PAM-1 cells were incubated with exon A antibody, and PAM-antibody complexes were internalized for 60 min at 20°C to load late endocytic compartments (Fig. 9, B-D) . As expected, vesicular structures containing PAM-antibody complexes were distributed throughout the cells (Fig. 9B, wide and narrow arrows) . As observed using the PAL antibody (Fig. 7, D and G) , after warming the control cells to 37°C and chasing for 30 or 60 min, the PAM-antibody complexes proceeded to collect in the TGN (Fig. 9, C and D,  wide arrows) .
To assess the effect of DRB on the endocytic trafficking of PAM-antibody complexes, 100 M DRB was added to PAM-1 cells that had been incubated for 30 min at 20°C with exon A antibody (Fig. 9, E-G) . Since DRB lacks specificity, PAM-1 TS/DD cells were treated in a similar fashion as a control. We reasoned that any effects of DRB on other phosphorylation events would still be apparent with the mutant PAM-1 TS/DD protein (data not shown). At the end of a 30-min (20°C) incubation with DRB, the DRB-treated PAM-1 cells differed only slightly from control cells (Fig. 9E) ; PAM antibody-containing vesicles were more dispersed and more prevalent at the tips of processes (narrow arrows). When the DRB-treated PAM-1 cells were chased for 30 or 60 min in the presence of the drug at 37°C, the cells showed little ability to collect internalized PAM-antibody complexes in the TGN region (Fig. 9, F and G) . PAM antibody-containing vesicles remained dispersed throughout the cells, with some concentration at the tips of processes (narrow arrows). DRB had no effect on the PAM-1 TS/DD cells (data not shown). Therefore, both our pharmacological and mutagenesis studies indicate the importance of the phosphorylation and dephosphorylation of Thr 946 and/or Ser 949 in trafficking from late endosomes into the TGN.
DISCUSSION
PAM Is Phosphorylated at Ser 949 -For many membrane proteins, phosphorylation of Ser/Thr residues located in acidic clusters in cytosolic COOH-terminal domains plays a crucial role in trafficking (6) . The region between Lys 953 and Lys 971 in the PAM-CD is extremely acidic and has typically been aligned with known acidic cluster trafficking signals. However, since truncation of PAM in the middle of this acidic region does not alter its trafficking, this acidic region is not a key trafficking determinant for PAM (20) . We demonstrate in this paper that Thr 946 and Ser 949 in the CD of PAM can be phosphorylated by CKII and by P-CIP2, transiently forming a short acidic cluster (Thr 946 -Glu-Gly-Ser 949 -Asp-Gln-Glu), and thus play a role in the trafficking of integral membrane PAM.
We used an antibody specific for P-Ser 949 to demonstrate that PAM-1 expressed in AtT-20 cells is phosphorylated at this site. Based on SDS-PAGE, both intact PAM-1 and the 70-kDa PAL fragment derived from it can be phosphorylated at Ser 949 . Based on the immunoprecipitation of PAM-1 with the P-Ser 949 -specific antibody, less than 5% of Ser 949 is phosphorylated at steady state. Nevertheless, the small fraction of PAM-1 that is phosphorylated on Ser 949 is localized to a discrete perinuclear area. Similarly, the single CKII phosphorylation site in CDMan-6-PR (EESEERDD) serves as a plasma membrane sorting signal despite the fact that only 3% of the protein is phosphorylated at this site at steady state (13) .
Mutagenesis studies suggest a role for the phosphorylation of Thr 946 and Ser 949 in the PAM-CD in the activation of PHM and access to secretory granules and endocytosis. The ability of the COOH-terminal domain of PAM to affect the specific activity of PHM was first appreciated when we observed an increase in PHM activity following partial proteolytic digestion of PAM (21) . Based on the ability of our P-Ser 949 antibody to recognize a conformation common to the PAM-1 TS/DD mutant protein and the increased aggregation of PAM-1 TS/DD at neutral pH, phosphorylation at this site may bring about a conformational change that affects the catalytic activity of the lumenal PHM domain.
The enzyme or enzymes responsible for phosphorylating PAM at Ser 949 in vivo have not been identified. Both CKII and P-CIP2 could be responsible for the phosphorylation of PAM at Ser 949 and are expressed in many of the tissues that express PAM (63, 64) . CKII, a highly conserved, ubiquitously expressed heterotetramer composed of catalytic (␣ and ␣Ј) and regulatory (␤) subunits, phosphorylates a wide range of substrates (65, 66) . In contrast, P-CIP2 is a highly selective kinase whose only known substrate is Ser 949 in the PAM-CD (25). Both P-CIP2 and CKII are inhibited by DRB, which blocks a late stage in the endocytosis of PAM-1 (Fig. 9) . The interaction of PAM-1 with P-CIP2 is complex. The P-CIP2-binding sites identified in the PAM-CD with the yeast two-hybrid system (K919R, L926Q, and F929A/F930A) are distinct from the residue phosphorylated by P-CIP2 (25, 26, 64) . In addition, PAM mutants unable to interact with P-CIP2 in a yeast two-hybrid assay can still be phosphorylated by P-CIP2. Finally, these P-CIP2 phosphorylated PAM mutants as well as PAM mutants that cannot be phosphorylated exhibit altered secretory phenotypes (26) .
Phosphorylation of Thr 946 and Ser 949 Affects Multiple Steps in PAM Trafficking-A simplified model of PAM-1 routing through the secretory pathway in AtT-20 cells is shown to aid in this discussion (Fig. 10) . PAM-1 is synthesized in the endoplasmic reticulum, and the N-linked oligosaccharide attached to PAM-1 acquires endoglycosidase H resistance as it traverses the Golgi (step 1) (67) . Cleavage to yield soluble PHM and membrane PAL occurs only after entry into immature secretory granules, and it can be blocked by incubation at 20°C (step 2) (35) . Soluble PHM is either stored in mature secretory granules until release is stimulated (steps 3 and 4) (68) or it exits in constitutive-like vesicles that bud from immature secretory granules, accounting for basal secretion (not shown) (69, 70) . Intact PAM-1 and membrane PAL are also retrieved from immature secretory granules in constitutive-like vesicles, and they recycle to the TGN through late endosomes (steps 5 and 8). Any PAM-1 or membrane PAL on the cell surface is internalized, traversing early and late/recycling endocytic compartments before returning to the TGN (steps 6 -8) (11, 22) .
Although the steady-state localization of PAM-1 TS/AA in AtT-20 cells is somewhat more diffuse than that of PAM-1, the response of each protein to nocodazole treatment is similar. In contrast, in the AtT-20 PAM-1 TS/DD cells, PAM staining was partially localized to the perinuclear region with more PAM localized to vesicular structures at the tips of processes. These vesicles are thought to be secretory granules since regulated secretion is enhanced in these cells, and adrenocorticotropincontaining vesicles are localized to this region in AtT-20 PAM-1 TS/DD cells (26) . Following nocodazole treatment, PAM-1 TS/DD staining in the perinuclear region was dispersed, suggesting that PAM-1 TS/DD was largely localized to late/recycling endosomes (36) . Overall, the altered steady-state localization of the mutant PAM proteins reflects changes in both biosynthetic and endocytic trafficking with PAM-1 phosphorylated at Thr 946 /Ser 949 having an increased anterograde and retrograde movement through the cell.
The initial synthesis and subsequent oligosaccharide maturation (Fig. 10, step 1 The minimum number of PAM-1 trafficking events involved in its metabolism and the major subcellular compartments that contain PAM-1 are shown. Late/ recycling endosomes are the most sensitive and disperse from the perinuclear region first in a low-dose, short incubation with nocodazole and increased nocodazole dosage and incubation time causes dispersal of the TGN. PALm, 70-kDa membrane PAL; P, PAM-1 phosphorylation.
